172 related articles for article (PubMed ID: 37986833)
1. HDL Particle Concentration and Size Predict Incident Coronary Artery Disease Events in People with Type 1 Diabetes.
Costacou T; Vaisar T; Miller RG; Davidson WS; Heinecke JW; Orchard TJ; Bornfeldt KE
medRxiv; 2023 Nov; ():. PubMed ID: 37986833
[TBL] [Abstract][Full Text] [Related]
2. Sex differences in the associations of HDL particle concentration and cholesterol efflux capacity with incident coronary artery disease in type 1 diabetes: The RETRO HDLc cohort study.
Costacou T; Miller RG; Bornfeldt KE; Heinecke JW; Orchard TJ; Vaisar T
J Clin Lipidol; 2024; 18(2):e218-e229. PubMed ID: 38320926
[TBL] [Abstract][Full Text] [Related]
3. Flipped C-Terminal Ends of APOA1 Promote ABCA1-Dependent Cholesterol Efflux by Small HDLs.
He Y; Pavanello C; Hutchins PM; Tang C; Pourmousa M; Vaisar T; Song HD; Pastor RW; Remaley AT; Goldberg IJ; Costacou T; Sean Davidson W; Bornfeldt KE; Calabresi L; Segrest JP; Heinecke JW
Circulation; 2024 Mar; 149(10):774-787. PubMed ID: 38018436
[TBL] [Abstract][Full Text] [Related]
4. Flipped C-Terminal Ends of APOA1 Promote ABCA1-dependent Cholesterol Efflux by Small HDLs.
He Y; Pavanello C; Hutchins PM; Tang C; Pourmousa M; Vaisar T; Song HD; Pastor RW; Remaley AT; Goldberg IJ; Costacou T; Davidson WS; Bornfeldt KE; Calabresi L; Segrest JP; Heinecke JW
medRxiv; 2023 Nov; ():. PubMed ID: 37961344
[TBL] [Abstract][Full Text] [Related]
5. Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives Atherosclerosis.
Kothari V; Ho TWW; Cabodevilla AG; He Y; Kramer F; Shimizu-Albergine M; Kanter JE; Snell-Bergeon J; Fisher EA; Shao B; Heinecke JW; Wobbrock JO; Lee WL; Goldberg IJ; Vaisar T; Bornfeldt KE
Circ Res; 2024 Jun; ():. PubMed ID: 38828596
[TBL] [Abstract][Full Text] [Related]
6. Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.
He Y; Ronsein GE; Tang C; Jarvik GP; Davidson WS; Kothari V; Song HD; Segrest JP; Bornfeldt KE; Heinecke JW
Circ Res; 2020 Oct; 127(9):1198-1210. PubMed ID: 32819213
[TBL] [Abstract][Full Text] [Related]
7. HDL particle size is increased and HDL-cholesterol efflux is enhanced in type 1 diabetes: a cross-sectional study.
Ahmed MO; Byrne RE; Pazderska A; Segurado R; Guo W; Gunness A; Frizelle I; Sherlock M; Ahmed KS; McGowan A; Moore K; Boran G; McGillicuddy FC; Gibney J
Diabetologia; 2021 Mar; 64(3):656-667. PubMed ID: 33169205
[TBL] [Abstract][Full Text] [Related]
8. Cell-free, high-density lipoprotein-specific phospholipid efflux assay predicts incident cardiovascular disease.
Sato M; Neufeld EB; Playford MP; Lei Y; Sorokin AV; Aponte AM; Freeman LA; Gordon SM; Dey AK; Jeiran K; Hamasaki M; Sampson ML; Shamburek RD; Tang J; Chen MY; Kotani K; Anderson JL; Dullaart RP; Mehta NN; Tietge UJ; Remaley AT
J Clin Invest; 2023 Sep; 133(18):. PubMed ID: 37471145
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of HDL function in patients with coronary artery disease: relationship with coronary plaque characteristics and clinical events.
Magnoni M; Andreini D; Pirillo A; Uboldi P; Latini R; Catapano AL; Maggioni AP; Norata GD;
Ann Med; 2022 Dec; 54(1):1036-1046. PubMed ID: 35438019
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
[TBL] [Abstract][Full Text] [Related]
11. Statins influence the relationship between ATP-binding cassette A1 membrane transporter-mediated cholesterol efflux capacity and coronary atherosclerosis in rheumatoid arthritis.
Karpouzas GA; Papotti B; Ormseth SR; Palumbo M; Hernandez E; Adorni MP; Zimetti F; Budoff MJ; Ronda N
J Transl Autoimmun; 2023 Dec; 7():100206. PubMed ID: 37484708
[TBL] [Abstract][Full Text] [Related]
12. Low concentrations of medium-sized HDL particles predict incident CVD in chronic kidney disease patients.
Shao B; Afshinnia F; Mathew AV; Ronsein GE; Thornock C; Irwin AD; Kansal M; Rao PS; Dobre M; Al-Kindi S; Weir MR; Go A; He J; Chen J; Feldman H; Bornfeldt KE; Pennathur S;
J Lipid Res; 2023 Jun; 64(6):100381. PubMed ID: 37100172
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen promotes cholesterol efflux by the ABCA1 pathway.
Pamir N; Hutchins PM; Ronsein GE; Wei H; Tang C; Das R; Vaisar T; Plow E; Schuster V; Koschinsky ML; Reardon CA; Weinberg R; Dichek DA; Marcovina S; Getz GS; Heinecke JW
JCI Insight; 2017 Aug; 2(15):. PubMed ID: 28768900
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol Efflux Capacity and Subclasses of HDL Particles in Healthy Women Transitioning Through Menopause.
El Khoudary SR; Hutchins PM; Matthews KA; Brooks MM; Orchard TJ; Ronsein GE; Heinecke JW
J Clin Endocrinol Metab; 2016 Sep; 101(9):3419-28. PubMed ID: 27399353
[TBL] [Abstract][Full Text] [Related]
15. HDL Cholesterol Efflux Predicts Incident New-Onset Diabetes After Transplantation (NODAT) in Renal Transplant Recipients Independent of HDL Cholesterol Levels.
Szili-Torok T; Annema W; Anderson JLC; Bakker SJL; Tietge UJF
Diabetes; 2019 Oct; 68(10):1915-1923. PubMed ID: 31375510
[TBL] [Abstract][Full Text] [Related]
16. Differential Effects of Genetically Determined Cholesterol Efflux Capacity on Coronary Artery Disease and Ischemic Stroke.
Jin A; Wang M; Chen W; Yan H; Xiang X; Pan Y
Front Cardiovasc Med; 2022; 9():891148. PubMed ID: 35859596
[TBL] [Abstract][Full Text] [Related]
17. The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
Asztalos BF; Hauser TH; Goldfine AB; Welty FK; Horvath KV; Schaefer EJ
Atherosclerosis; 2022 Mar; 345():1-6. PubMed ID: 35183903
[TBL] [Abstract][Full Text] [Related]
18. Increased ABCA1 (ATP-Binding Cassette Transporter A1)-Specific Cholesterol Efflux Capacity in Schizophrenia.
Luquain-Costaz C; Kockx M; Anastasius M; Chow V; Kontush A; Jessup W; Kritharides L
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2728-2737. PubMed ID: 32907370
[TBL] [Abstract][Full Text] [Related]
19. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study.
Saleheen D; Scott R; Javad S; Zhao W; Rodrigues A; Picataggi A; Lukmanova D; Mucksavage ML; Luben R; Billheimer J; Kastelein JJ; Boekholdt SM; Khaw KT; Wareham N; Rader DJ
Lancet Diabetes Endocrinol; 2015 Jul; 3(7):507-13. PubMed ID: 26025389
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
